Literature DB >> 19409299

Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development.

Devalingam Mahalingam1, Alain Mita, Monica M Mita, Steffan T Nawrocki, Francis J Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19409299     DOI： 10.1016/j.currproblcancer.2009.03.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  12 in total

Review 1.  Advances in cancer therapeutics and patient access to new drugs.

Authors:  George Dranitsaris; Ilse Truter; Martie S Lubbe; Eitan Amir; William Evans
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

2.  Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer.

Authors:  Jian Chen; Lijuan Hu; Fan Zhang; Junjun Wang; Jie Chen; Yumin Wang
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

3.  Thoracic cancers - cautious optimism replaces abject nihilism.

Authors:  C S Pramesh
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

4.  Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies.

Authors:  Ramon Andrade de Mello; Dânia Sofia Marques; Rui Medeiros; António Mf Araújo
Journal:  World J Clin Oncol       Date:  2011-11-10

5.  EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study.

Authors:  Ramon Andrade de Mello; Filipa Soares Pires; Dânia Sofia Marques; Júlio Oliveira; Ana Rodrigues; Marta Soares; Isabel Azevedo; Ana Peixoto; Catarina Santos; Carla Pinto; Venceslau Hespanhol; Manuel R Teixeira; Teresina Amaro; Henrique Queiroga; António Araújo
Journal:  Tumour Biol       Date:  2012-07-29

6.  A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.

Authors:  Ayad A Al-Hamashi; Radhika Koranne; Samkeliso Dlamini; Abdulateef Alqahtani; Endri Karaj; Maisha S Rashid; Joseph R Knoff; Matthew Dunworth; Mary Kay H Pflum; Robert A Casero; Lalith Perera; William R Taylor; L M Viranga Tillekeratne
Journal:  Bioorg Chem       Date:  2021-08-30       Impact factor: 5.275

7.  Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan.

Authors:  Jason C Hsu; Luis A Gonzalez-Gonzalez; Vicky H Lu; Christine Y Lu
Journal:  BMJ Open       Date:  2016-05-27       Impact factor: 2.692

8.  BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.

Authors:  S Elizabeth Franks; Robert A Jones; Ritesh Briah; Payton Murray; Roger A Moorehead
Journal:  BMC Res Notes       Date:  2016-03-01

9.  Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells.

Authors:  Efstathia Giannopoulou; Achilleas Nikolakopoulos; Dimitra Kotsirilou; Angeliki Lampropoulou; Sofia Raftopoulou; Evangelia Papadimitriou; Achilleas D Theocharis; Thomas Makatsoris; Konstantinos Fasseas; Haralabos P Kalofonos
Journal:  J Biomed Sci       Date:  2015-10-24       Impact factor: 8.410

10.  Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study.

Authors:  Jason C Hsu; Christine Y Lu
Journal:  BMJ Open       Date:  2016-06-06       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.